Target intelligence / Profile preview

MTSS I-BAR domain containing 2 (MTSS2)

Target
MTSS2
Molecular classification
Other (I-BAR domain-containing membrane and actin regulator protein)
01

Overview

MTSS I-BAR domain containing 2 (MTSS2), also called MTSS1L or ABBA, is a member of the I-BAR (Inverse Bin/Amphiphysin/Rvs) domain protein family, characterized by an N-terminal I-BAR domain that binds plasma membranes and induces negative membrane curvature, and a C-terminal actin-binding WH2 domain. MTSS2 is predominantly expressed in the central nervous system, especially in neurons, and is implicated in the formation and plasticity of synaptic structures such as dendritic spines. The protein participates in linking dynamic membrane shaping to actin cytoskeleton remodeling and has GTPase activator and small GTPase binding capacities. Human genetic variants in MTSS2 are associated with a syndromic form of intellectual disability, often including microcephaly and eye anomalies, suggesting its critical role in neurodevelopment and synaptic function. There are currently no drugs or established biomarkers directly targeting MTSS2, and it is not a recognized therapeutic target.

Other names
MTSS1-like proteinMTSS1LABBAABBA-1LOC92154Actin-bundling with BAIAP2 homology protein 1actin-bundling protein with BAIAP2 homologyIDDOFprotein MTSS 2metastasis suppressor 1-like
02

Biological functions

Modulation of membrane curvature and formation of plasma membrane protrusionsRegulation of actin cytoskeleton dynamicsActivity-dependent synaptic plasticityGTPase activator activitySmall GTPase bindingCellular response to growth factor stimuli (e.g. platelet-derived growth factor)
03

Disease associations

Syndromic intellectual disability with ocular anomalies and distinctive facial features

Beyond the preview

Go deeper on MTSS I-BAR domain containing 2 (MTSS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTSS I-BAR domain containing 2 (MTSS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call